310 related articles for article (PubMed ID: 23381003)
1. Translating metastasis-related biomarkers to the clinic--progress and pitfalls.
Bidard FC; Pierga JY; Soria JC; Thiery JP
Nat Rev Clin Oncol; 2013 Mar; 10(3):169-79. PubMed ID: 23381003
[TBL] [Abstract][Full Text] [Related]
2. PCR- and RT-PCR-based methods of tumor detection: potential applications and clinical implications.
Seiden M; Sklar JL
Important Adv Oncol; 1996; ():191-204. PubMed ID: 8791136
[No Abstract] [Full Text] [Related]
3. Circulating biomarkers to guide systemic therapy for urothelial carcinoma.
Abbosh PH; Rosenberg JE; Plimack ER
Urol Oncol; 2016 Nov; 34(11):502-509. PubMed ID: 27751785
[TBL] [Abstract][Full Text] [Related]
4. HCMDB: the human cancer metastasis database.
Zheng G; Ma Y; Zou Y; Yin A; Li W; Dong D
Nucleic Acids Res; 2018 Jan; 46(D1):D950-D955. PubMed ID: 29088455
[TBL] [Abstract][Full Text] [Related]
5. microRNAs as cancer biomarkers.
Flatmark K; Høye E; Fromm B
Scand J Clin Lab Invest Suppl; 2016; 245():S80-3. PubMed ID: 27542003
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
[TBL] [Abstract][Full Text] [Related]
7. microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies.
Gandellini P; Doldi V; Zaffaroni N
Semin Cancer Biol; 2017 Jun; 44():132-140. PubMed ID: 28344166
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
[TBL] [Abstract][Full Text] [Related]
9. Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance.
Hu HF; Xu WW; Zhang WX; Yan X; Li YJ; Li B; He QY
Signal Transduct Target Ther; 2020 Nov; 5(1):271. PubMed ID: 33243974
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of microRNA-326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting SMO expression.
Huang JH; Xu Y; Lin FY
J Cell Mol Med; 2020 Sep; 24(18):10876-10888. PubMed ID: 32743904
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
[TBL] [Abstract][Full Text] [Related]
12. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
[TBL] [Abstract][Full Text] [Related]
13. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
14. Pseudogene Profiling for Cancer Subtype Classification.
Zhang Y; Zheng D
Methods Mol Biol; 2021; 2324():307-317. PubMed ID: 34165723
[TBL] [Abstract][Full Text] [Related]
15. The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy.
Naeli P; Yousefi F; Ghasemi Y; Savardashtaki A; Mirzaei H
Curr Mol Med; 2020; 20(2):90-101. PubMed ID: 31573883
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic biomarkers in the development of stratified cancer medicine.
Figg WD; Newell DR
Clin Cancer Res; 2014 May; 20(10):2525-9. PubMed ID: 24831275
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MDR1 gene in human cancers.
Goldstein LJ; Gottesman MM; Pastan I
Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
[No Abstract] [Full Text] [Related]
18. Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.
Gao H; Chakraborty G; Lee-Lim AP; Mavrakis KJ; Wendel HG; Giancotti FG
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16532-7. PubMed ID: 25378704
[TBL] [Abstract][Full Text] [Related]
19. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarker of metastatic melanoma.
Torres-Collado AX; Jazirehi AR
Epigenomics; 2013 Aug; 5(4):366. PubMed ID: 24303558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
